Literature DB >> 15991220

Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.

G Broccia1, Wilma Deplano, P Dessalvi, Barbara Giannico, G Luxi, E Chessa, Antonietta Murru.   

Abstract

We have collected, by an active retrospective survey, all the cases of hematologic malignancies (HM) newly diagnosed during the time period 1974-1993 in the resident population of Sardinia. Diagnosis was deemed valid, after consultation of clinical records, in more than 90% of the 7264 collected cases. The number of newly diagnosed cases by year more than doubled during the 20-year period investigated. This striking increase can be only partially accounted for by ageing of population. Indeed, age-specific and age-adjusted rates of most of HM increased during this period, although Hodgkin Disease (HD), Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) were notable exceptions. The observed increase in rates is likely, in a large part, to be fictitious, due to easier access to a health care system, which in the meantime, improved its diagnostic efficiency. This was particularly evident for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and some others myelo- and lympho-proliferative disorders, but its relevance declined after 1984-1989. A likely true increase in occurrence was evidenced for Non-Hodgkin Lymphomas (NHL) and similarly, although to a lesser extent and more doubtful, for Myelodysplasias (MDS) and Acute Myeloid Leukemia (AML). At the end of the studied period each type of HM presented age and sex distributions and age-adjusted rates that show only minor differences from those reported for other western countries. No argument emerged to suggest that any genetic peculiarities of the Sardinian population might have affected the occurrence of HM. The confounding effects of improved diagnostic efficiency have prevented a reliable assessment of influence on incidences of environmental and socio-economic changes that, in relatively recent times, have occurred in Sardinia. Copyright 2005 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2004        PMID: 15991220     DOI: 10.1002/hon.733

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  5 in total

1.  Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).

Authors:  Marc Maynadié; François Girodon; Ines Manivet-Janoray; Morgane Mounier; Francine Mugneret; François Bailly; Bernardine Favre; Denis Caillot; Tony Petrella; Michel Flesch; Paule-Marie Carli
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

2.  Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.

Authors:  Gemma Osca-Gelis; Montserrat Puig-Vives; Marc Saez; David Gallardo; Natalia Lloveras; Rafael Marcos-Gragera
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 3.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

4.  Hematological malignancies in Al-amal oncology unit, aden.

Authors:  Waiel Al-Kahiry
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-18       Impact factor: 0.900

5.  Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.

Authors:  Marta Solans; Arantza Sanvisens; Alberto Ameijide; Susana Merino; Dolores Rojas; Araceli Alemán; Emilia Banqueri; Matilde Chico; Ana Isabel Marcos; Visitación de Castro; Leire Gil; Arantza López de Munain; Montse Puigdemont; Maria-José Sánchez; Josefina Perucha; Patricia Ruiz-Armengol; Mª Dolores Chirlaque; Marcela Guevara; Marià Carulla; Rafael Marcos-Gragera
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.